Persistent COVID-19 symptoms in a community study of 606,434 people in England
2022 · Nature Communications · 426 citations
https://doi.org/10.1038/s41467-022-29521-z
M
Matthew Whitaker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
3.3K
Citations
25
h-index
40
i10-index
Matthew Whitaker is an academic researcher from NIHR Imperial Biomedical Research Centre. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & SARS-CoV-2 detection and testing. The author has an h-index of 25, co-authored 63 publications.
ORCID: 0000-0003-1363-6537Papers by this author
worksPopulation antibody responses following COVID-19 vaccination in 212,102 individuals
2022 · Nature Communications · 165 citations
https://doi.org/10.1038/s41467-022-28527-x
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England
2022 · Nature Communications · 136 citations
https://doi.org/10.1038/s41467-022-34244-2
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
2021 · The Lancet Regional Health - Europe · 105 citations
https://doi.org/10.1016/j.lanepe.2021.100098
SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people
2023 · Nature Communications · 11 citations
https://doi.org/10.1038/s41467-023-40643-w
Profiling vaccine attitudes and subsequent uptake in 1·1 million people in England: a nationwide cohort study
2026 · The Lancet · 3 citations
https://doi.org/10.1016/s0140-6736(25)01912-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat